.

Acorda Therapeutics reported $-46682000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -34.01M 79.04M
Acorda Therapeutics ACOR:US $ -46.68M 22.16M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
ALKERMES ALKS:US $ -30.14M 5.77M
Amgen AMGN:US $ 1317M 159M
Anika Therapeutics ANIK:US $ -2.84M 0.09M
Aptinyx Inc APTX:US $ -17667000 2.16M
Arrowhead Research ARWR:US $ -72046000 116.41M
Biogen BIIB:US $ 1058M 754.2M
Biomarin Pharmaceutical BMRN:US $ 27.66M 93.13M
Cara Therapeutics CARA:US $ -4206000 23.54M
Clovis Oncology CLVS:US $ -71.33M 11.16M
Cytokinetics CYTK:US $ -19.82M 69.62M
Enanta Pharmaceuticals ENTA:US $ -31.7M 1.89M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 83800M 96400M
Halozyme Therapeutics HALO:US $ 22.68M 37.42M
Insmed INSM:US $ -95645000 1.02M
Mannkind MNKD:US $ -29.02M 3.02M
Merck MRK:GR € 867M 14M
Moderna Inc MRNA:US 2.2B 1.46B
Neurocrine Biosciences NBIX:US $ -16.9M 30.8M
Novartis NOVN:VX SF 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Teva Pharmaceutical TEVA:IT -233000000 722M
Ultragenyx Pharmaceutical RARE:US $ -158.16M 5.84M
Vertex Pharmaceuticals VRTX:US $ 810.5M 48.4M